✦ LIBER ✦

Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer

✍ Scribed by Allyson J. Ocean; Paul Christos; Joseph A. Sparano; Dan Matulich; Andreas Kaubish; Abby Siegel; Max Sung; Maureen M. Ward; Nancy Hamel; Igor Espinoza-Delgado; Yun Yen; Maureen E. Lane

Publisher: Springer
Year: 2010
Tongue: English
Weight: 273 KB
Volume: 68
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1481-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of 3-aminopyridine-2-car

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

✍ Yun Yen; Kim Margolin; James Doroshow; Mayer Fishman; Bonny Johnson; Caroline Cl 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 233 KB

Phase II trial of gemcitabine combined w

Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

✍ Jeeyun Lee; Tae-You Kim; Myung Ah Lee; Myung Ju Ahn; Hoon-Kyo Kim; Ho Yeong Lim; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 246 KB

A Phase I study of the novel ribonucleot

A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders

✍ Judith E. Karp; Francis J. Giles; Ivana Gojo; Lawrence Morris; Jacqueline Greer; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB